Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
Provided By PR Newswire
Last update: Jul 29, 2025
CARY, N.C., July 28, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, August 11, 2025, at 4:30 p.m. ET to report second quarter 2025 financial results and discuss recent business highlights.
Read more at prnewswire.com
